Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

statins, cancer risk, AACR, Frontiers in Cancer Prevention Research Conference, American Association for Cancer Research

November 9, 2010 12:36 pm | by AACR | News | Comments

PHILADELPHIA — Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010,...

TOPICS:

Use of Androgen Deprivation Therapy Increases Fracture Risk Among Prostate Cancer Patients

November 9, 2010 12:35 pm | by AACR | News | Comments

PHILADELPHIA — Men with history of fracture and comorbidities are at an increased risk of fracture after long-term use of androgen deprivation therapy, and initiating this therapy should be carefully considered in older men with localized prostate cancer.

TOPICS:

Home Exposure to Tobacco Carcinogens High in Children of Smokers

November 9, 2010 12:35 pm | by AACR | News | Comments

PHILADELPHIA — Ninety percent of children who lived in a house where an adult smoked had evidence of tobacco-related carcinogens in their urine, according to research presented at the Ninth AACR Frontiers in Cancer Prevention Research Conference, held here from Nov 7-10, 2010.

TOPICS:
Advertisement

Very Few Eligible Young Women Opt to Take HPV Vaccine

November 9, 2010 12:34 pm | by AACR | News | Comments

PHILADELPHIA — Despite strong evidence of its effectiveness, few of the young women who are eligible for the human papillomavirus (HPV) vaccine take it, according to research presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10. What’s...

TOPICS:

TTI: The Big Job- "Specialist Campaign Speech"

November 9, 2010 12:32 pm | by ttithebigjob | Videos | Comments

http://www.ttiinc.com/thebigjob

TTI: The Big Job- "Preston the Parakeet Campaign Speech"

November 9, 2010 12:31 pm | by ttithebigjob | Videos | Comments

http://www.ttiinc.com/thebigjob

Gentiva Health 3Q profit falls on costs

November 9, 2010 10:45 am | by The Associated Press | News | Comments

Home health care services company Gentiva Health Services Inc. said Tuesday its third-quarter profit fell 47 percent on higher costs following the $1 billion buyout of hospice care company Odyssey Healthcare Inc.The company closed the buyout in August.Gentiva earned $8.1 million, or 27 cents...

Jefferson awarded multi-million dollar NIH grant

November 9, 2010 10:38 am | by EurekAlert | News | Comments

(Thomas Jefferson University) Researchers in the Departments of Psychiatry and Neurology at Jefferson Medical College of Thomas Jefferson University were recently awarded a $2.6 million grant from the National Institutes of Health to study whether increasing participation in...

TOPICS:
Advertisement

Symposium in Vietnam to discuss integrated approach to defeating diarrheal disease

November 9, 2010 10:37 am | by EurekAlert | News | Comments

(PATH) Each year, diarrhea claims the lives of 1.3 million children under five worldwide. Fortunately, interventions exist that can greatly reduce deaths and save lives. To bring attention to the solutions available today for defeating diarrhea, the Vietnam Ministry of Health the...

TOPICS:

2010 Prevention: “Cancer Prevention Among Women” Teleconference

November 9, 2010 10:36 am | by AACR | News | Comments

Moderated by Judy Garber, M.D., M.P.H., president-elect of the American Association for Cancer Research and leader of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute

TOPICS:

Prevention 2010: Interview with Avrum E. Spira, M.D., M.Sc.

November 9, 2010 10:34 am | by AACR | News | Comments

Interview with Avrum E. Spira, M.D., M.Sc., chief, division of computational biomedicine and director of the translational bioinformatics program at Boston University’s Clinical and Translational Science Institute

TOPICS:

Emeritus 5M-share offering priced at $18.25 each

November 9, 2010 9:45 am | by The Associated Press | News | Comments

Emeritus Corp. said Tuesday an underwritten public offering of 5 million of its shares was priced at $18.25 each.The company plans to sell 4 million shares, while shareholders will sell 1 million shares. Emeritus will not receive any proceeds from the sale of shares by shareholders.Emeritus has...

Study shows durable viral suppression of boosted REYATAZ in treatment-experienced HIV patients

November 9, 2010 9:36 am | by EurekAlert | News | Comments

(TogoRun) Results from a European Observational Study, which included 1,294 antiretroviral-experienced patients presented today at the Tenth International Congress on Drug Therapy in HIV Infection, demonstrated a low rate of discontinuation and sustained virologic suppression with...

TOPICS:

Portable microwave sensors for measuring vital signs

November 9, 2010 9:36 am | by EurekAlert | News | Comments

(American Institute of Physics) Current medical techniques for monitoring the heart rate and other vital signs use electrodes attached to the body, which are impractical for patients who want to move around. Plasma physicist Atsushi Mase, a scientist at Kyushu University in Japan,...

TOPICS:

Synageva lands orphan drug status in Europe

November 9, 2010 9:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Synageva BioPharma Corp. has won orphan drug status from the European Medicines Agency (EMA) for its enzyme replacement therapy, SBC-102, to treat Lysosomal Acid Lipase Deficiency.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading